For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News
Russian Antiviral Drug Ingavirin Found Effective Against Human Metapneumovirus, Insights from a 2012 Study
Nikhil Prasad Fact checked by:Thailand Medical News Team Jan 06, 2025 1 day, 11 hours, 53 minutes ago
Medical News: A breakthrough study published in 2012 sheds light on the potential of Ingavirin, a Russian antiviral medication, to combat human metapneumovirus (HMPV), a common yet underappreciated cause of respiratory infections. Conducted by researchers at the D.I. Ivanovsky Research Institute of Virology, the investigation provides compelling evidence of the drug’s effectiveness when tested in vitro. https://pubmed.ncbi.nlm.nih.gov/22624471/
Russian Antiviral Drug Ingavirin Found Effective Against Human Metapneumovirus, Insights from a 2012 Study
Understanding the Study
The study explored the antiviral properties of Ingavirin using the human cell line ChangConjunctiva, clone 1-5C4, which is highly permissive to HMPV infection. Researchers utilized an HMPV strain isolated specifically for the study. Ingavirin, applied at concentrations ranging from 50 to 500 micrograms per milliliter (µg/ml), demonstrated significant antiviral effects. When added to the nutrient medium 24 hours post-infection, the drug suppressed virus replication by 2.2 to 3.3 logarithmic scales, depending on the dosage. Notably, when Ingavirin was applied at 500 µg/ml 24 hours before infection, it effectively protected the cells against HMPV, highlighting its potential as both a therapeutic and preventive measure.
This Medical News report emphasizes the importance of these findings, as HMPV often goes undiagnosed, despite being a significant contributor to respiratory illnesses worldwide. Symptoms of HMPV range from mild cold-like conditions to severe respiratory distress, particularly in children, the elderly, and immunocompromised individuals.
How Ingavirin Works
Ingavirin, chemically known as imidazolyl ethanamide pentandioic acid, is a unique compound recognized for its broad-spectrum antiviral properties. https://pubchem.ncbi.nlm.nih.gov/compound/Ingavirin
It works by interfering with the replication mechanisms of viruses and enhancing the immune response. Although originally designed to treat influenza and other respiratory viruses, the 2012 study highlights its potential against HMPV, offering hope for addressing a long-overlooked health challenge.
Conclusion
The 2012 findings position Ingavirin as a promising option for treating HMPV infections. Its ability to reduce viral replication and protect cells underscores its versatility as an antiviral agent. However, further clinical trials are essential to confirm its efficacy and safety in humans.